Custom program helps people living with diabetes control blood sugar Dr. Nandita Mohan10 Jun 2022 9:00 AM ISTStudy results from three clinical trials has showed that a "WeightWatchers" program which was tailored for people living with diabetes helped...
AI Offers Significant Rate of Remission for Type 2 Diabetes Compared to Standard Care Dr. Kamal Kant Kohli9 Jun 2022 7:30 PM ISTA new study powered by artificial intelligence (AI), Whole Body Digital Twin, reveals the highest reported rate of remission of type 2 diabetes to...
Individuals with Diabetes Up to Four Times More Likely to Develop Long COVID-19 Dr. Kamal Kant Kohli7 Jun 2022 9:30 AM ISTA new study reveals that diabetes is a potential risk factor for post-acute sequelae of COVID-19 (PASC), also known as long COVID-19, a range of...
Tirzepatide Slows CKD Progression among diabetes patients with Increased CV risk Dr. Kamal Kant Kohli7 Jun 2022 9:15 AM ISTTirzepatide can slow progression of chronic kidney disease in type 2 diabetes according to an analysis of SURPASS-4 data presented at ADA 2022. In...
High HbA1C increases hospitalization in Covid-19 patients with diabetes Medical Dialogues Editorial Team24 March 2022 9:45 AM ISTIn individuals with type 2 diabetes (T2D) with COVID-19 infection in the United States, the probability of hospitalization increased with increasing...
Extreme HbA1c values shows association with a higher sepsis occurrence MD Editorial Team7 Jan 2022 9:45 AM ISTIn a new study led by Anca Balintescu and colleagues, researchers discovered association between HbA1c and sepsis, as well as a fourfold increased...
Pharmacological Treatment of Diabetes: ADA 2022 explores beyond metformin as initial therapy Dr. Prem Aggarwal24 Dec 2021 4:00 PM ISTNew Delhi: Metformin has been the cornerstone of Diabetes management for a long time. However, with the growing research in the field of diabetes and...
Patients of diabetic foot ulcer have greater odds of dying than undergoing amputation: Study MD Editorial Team16 Dec 2021 9:00 AM ISTAccording to a new study conducted by Rosemary C. Chamberlain and colleagues, death is a greater risk than amputation among diabetes patients. The...
RYGB reduces microalbuminuria and A1c better than empagliflozin and liraglutide: Study Dr. Shravani Dali28 Oct 2021 10:00 AM ISTIndividuals who receive Roux-en-Y Gastric Bypass have a greater reduction in microalbuminuria and A1c compared with those treated with empagliflozin...
Molidustat, a promising drug to minimize HF risk following heart attack in diabetics MD Editorial Team24 Oct 2021 6:03 PM ISTA drug molidustat has been identified by researchers at University of Oxford, that may help improve heart function in diabetics who have heart...
180-day implantable CGM found safe and effective for managing blood sugar: Study MD Bureau14 July 2021 9:00 AM ISTA 180-day implantable continuous glucose monitor was found to be safe and effective for use among diabetic patients.
Tools to decrease hypoglycemia may improve sleep quality in young diabetics: Study Dr. Shravani Dali7 July 2021 11:30 AM ISTImproved hypoglycemia can be linked to quality sleep in the youth suffering from Type-1 diabetes, suggests a study published in the Diabetes journal...
